Inspira Technologies
Ra'anana, Israel· Est.
Innovative non‑invasive respiratory support platform that could replace mechanical ventilators in critical care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative non‑invasive respiratory support platform that could replace mechanical ventilators in critical care.
RespiratoryCritical Care
Technology Platform
Adaptive blood oxygenation via a dual‑lumen cannula (VORTX™) combined with continuous real‑time blood monitoring (HYLA™ sensor) and AI‑driven decision support.
Opportunities
Potential to capture a sizable share of the $19 B mechanical ventilation market by offering a less invasive, cost‑effective alternative and to expand into emerging markets with limited ICU infrastructure.
Risk Factors
Regulatory approval timelines for ART500, reimbursement uncertainty, and competition from established ventilator and ECMO manufacturers could delay commercialization.
Competitive Landscape
Competes with traditional mechanical ventilators, ECMO systems, and emerging non‑invasive respiratory devices; differentiation lies in its blood‑oxygenation approach and integrated real‑time monitoring.